OIM
Oracle Investment Management Portfolio holdings
AUM
$116M
1-Year Return
84.31%
This Quarter Return
+10.55%
1 Year Return
+84.31%
3 Year Return
+539.5%
5 Year Return
+791.07%
10 Year Return
+13,222.09%
AUM
$763M
AUM Growth
+$39.8M
(+5.5%)
Cap. Flow
-$1.21M
Cap. Flow
% of AUM
-0.16%
Top 10 Holdings %
Top 10 Hldgs %
72.89%
Holding
32
New
5
Increased
8
Reduced
6
Closed
4
Top Buys
| 1 |
RPTP
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
|
$20.4M |
| 2 |
CMRX
Chimerix, Inc.
CMRX
|
$14.9M |
| 3 |
Abeona Therapeutics
ABEO
|
$9.27M |
| 4 |
Cerus
CERS
|
$6.36M |
| 5 |
BIOL
Biolase, Inc.
BIOL
|
$5.41M |
Top Sells
| 1 |
ACOR
Acorda Therapeutics, Inc.
ACOR
|
$33.4M |
| 2 |
MZOR
Mazor Robotics Ltd.
MZOR
|
$12.8M |
| 3 |
RPRX
Repros Therapeutics Inc.
RPRX
|
$10M |
| 4 |
Opko Health
OPK
|
$4.89M |
| 5 |
DSCI
Derma Sciences, Inc. Common Stock (DE)
DSCI
|
$2.72M |
Sector Composition
| 1 | Healthcare | 80.64% |
| 2 | Consumer Staples | 0.43% |
| 3 | Financials | 0.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Biogen
BIIB
$20.5B
| $2.62M | 0.34% |
7,723
| – | – |
|
|
LTS
27
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
| $442K | 0.06% |
111,789
| – | – |
|
28
Lexicon Pharmaceuticals
LXRX
$389M
| $216K | 0.03% |
+33,868
| New | +$216K |
|
29
Celldex Therapeutics
CLDX
$1.51B
| – | – |
-1,667
| Closed | -$324K |
|
|
ONCT
30
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| – | – |
-189
| Closed | -$196K |
|
|
DSCI
31
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
| – | – |
-326,844
| Closed | -$2.72M |
|
|
RPRX
32
DELISTED
Repros Therapeutics Inc.
RPRX
| – | – |
-1,014,164
| Closed | -$10M |
|